Kiler Immunoglobulin Receptor(KIR) Ligands Are Associated with At Least Partial (HLA A*03, B*44) or Poorer (HLA B*51, C*04) Response to Thalidomide Among Patients with Multiple Myeloma Treated in Two Turkish Centers


Suyani E., Bakanay S. M. , DALVA K., Cakmak E., Haznedar R., Sncak G., ...More

54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Georgia, United States Of America, 8 - 11 December 2012, vol.120 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 120
  • Doi Number: 10.1182/blood.v120.21.4904.4904
  • City: Georgia
  • Country: United States Of America